Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.

Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, Hughes MD; ALLRT team.

AIDS. 2010 Jul 31;24(12):1867-76. doi: 10.1097/QAD.0b013e32833adbcf.

2.

Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.

Siegfried N, Uthman OA, Rutherford GW.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008272. doi: 10.1002/14651858.CD008272.pub2. Review.

PMID:
20238364
3.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
4.

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR.

Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8. Review.

5.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
6.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
7.

HIV: new drugs, new guidelines.

Geretti AM, Tsakiroglou M.

Curr Opin Infect Dis. 2014 Dec;27(6):545-53. doi: 10.1097/QCO.0000000000000106. Review.

PMID:
25304395
8.

The future role of CD4 cell count for monitoring antiretroviral therapy.

Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, Davies MA, Grinsztejn B, Calmy A, Kumarasamy N, Phanuphak P, deBeaudrap P, Vitoria M, Doherty M, Stevens W, Siberry GK.

Lancet Infect Dis. 2015 Feb;15(2):241-7. doi: 10.1016/S1473-3099(14)70896-5. Epub 2014 Nov 19. Review.

PMID:
25467647
9.

Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question.

Eholié SP, Badje A, Kouame GM, N'takpe JB, Moh R, Danel C, Anglaret X.

AIDS Res Ther. 2016 Jul 26;13:27. doi: 10.1186/s12981-016-0111-1. eCollection 2016. Review.

10.

CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies.

Maina EK, Bonney EY, Bukusi EA, Sedegah M, Lartey M, Ampofo WK.

Immunol Lett. 2015 Dec;168(2):279-84. doi: 10.1016/j.imlet.2015.10.005. Epub 2015 Oct 22. Review.

PMID:
26475399
11.

Antiretroviral therapy: Shifting sands.

Sashindran VK, Chauhan R.

Med J Armed Forces India. 2016 Jan;72(1):54-60. doi: 10.1016/j.mjafi.2015.12.002. Epub 2016 Jan 5. Review.

PMID:
26900224
Items per page

Supplemental Content

Write to the Help Desk